Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Orca Bios BLA for Hematologic Malignancy Cell Therapy Orca-T Accepted by FDA With Priority Review October 7, 2025 Orca Bios BLA for Orca-T, an investigational allogeneic cell therapy product intended to treat various hematologic malignancies, including acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and myelodysplastic syndromes (MDS), has been accepted by the FDA with priority review
97. Pinto, D., Pagnamenta, A
Family: Oxidoreductase Sub Family: Reductase Organism: Rat Construct Details: Endogenous Assay Information Assay Type: Biochemical Assay Sub Type: Enzymatic Functional Mode: Antagonist Detection Method: EIA Measured Response: Absorbance Testing Information Procedure Summary: Rat liver steroid 5 alpha-reductase is used
ACS Infectious Diseases, 4 (1), 46
US$ 22.64
US$ 27.78
US$ 20.18
US$ 26.86
US$ 23.70
US$ 24.29
US$ 27.42
US$ 24.06
US$ 26.04
US$ 25.61
US$ 24.80
US$ 28.33
US$ 20.93
US$ 23.87
US$ 21.29
US$ 24.37
